BioNTech is one of the most recent companies to announce cuts, but the pace of job losses is slowing. There have been over 40 rounds of layoffs announced this year as of April 30, compared to more ...

In the year 2026, Artificial Intelligence is rapidly transforming the global job market, changing the skills employers look ...

Biopharma professionals hunting for their next role likely saw increased opportunities by the end of the first quarter, according to BioSpace data. Although job postings live on the BioSpace website ...

Bioversity, which spun out of MassBio in 2023, opened its first training center in Boston’s Dorchester neighborhood in ...

The Common University Entrance Test (CUET) , considered as one of the major university entrance tests, unifies all ...

Biopharma companies appear to be more willing to go public after a long drought. Just this week, GLP-1 developer Kailera Therapeutics and proteomics company Alamar Biosciences launched IPO roadshows ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. The U.S. labor market showed signs of improvement in March, with employers adding 178,000 ...

Have we passed the peak of biotech layoffs? It’s too early to say for certain—but an intriguing story is playing out in the figures. According to an analysis of Fierce Biotech’s layoff data, a total ...

Half a year after being spurned by the FDA and following deep layoffs, IO Biotech has decided to close its doors for good. The Danish biotech has ceased operations and said goodbye to its employees, C ...

A new Philly nonprofit is trying to close a gap in the city’s life sciences ecosystem: meaningful connections between students and industry professionals. After their own unconventional experiences ...

Management anticipates initiating dose expansion cohorts for VIR-5500 in the second quarter of 2026 and advancing into Phase III development in 2027. The company expects its cash runway, including ...